{"ticker": {"uuid": "893d6873-25f2-4df0-b9c8-da977ebd049e", "symbol": "RGT", "name": "Argent BioPharma Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Argent Biopharma Taps ASX for A$262,000 via Convertible Notes and 5.1 Million Unlisted Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE15QUg0cWVJWlVUbkFHREUwM0ppcmtQWmtaeVhmejBFbnFXU1lkWGcwX29FV0k1bjZwd0xhM0lzeEhQc2NpOUdVZUJERGhwVlVQbFd3VEt0TDFUZEp3SWdPQ0dnM245WTVJV3JLdm51aEdxODlYWHc?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-07-14T06:31:54+00:00", "published_display": "14 Jul 2026 06:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNcGptZ2NKMkZTWUlYLXBxRkJ2MkM2Sk4zU01vbXVUc2ltSXREd0VrSndxT2dOSzRVU2VObWdJNHFINS1XREZoQWJUQ1BHendWVXdGb2ZsV3VlR1k0STI2NVk4NnVycHppTktvU093dl81RmNSS3ktSkl3X0s3TC1pN2ZnTVp6bUQwQ0g3c2t3YkowaUlvVnQ2dHYxOWlaSkg0MWZQYXY4VnJocVNWNmlQbG0tZnZnNWE5TThzMWk3akJVYjU0by0wellhb0sxbWZZZFNoQnBGckRTeFZINzViZTRkT2FSSi03NWk3OFJMQXhpdEh5UTBv?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T13:48:00+00:00", "published_display": "13 Jul 2026 13:48", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Argent Biopharma Ltd \u2013 ASX:RGT", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNbDE5SzNianlndnZPQkctVEpEOFdmRjBCRG45b1VFVFQ5a2hmZndqZk1IYUVCYndCVUdXWGJLdkVWNHRQRnlEcjZVWU9uQm50QkhjbHpXbE1FMDBkdkxxZnNtU1hhbm9WT3JqMWtGUDN5Uk5GRlhvZ2V5ZGgwN0dqcXpVYUgyLVNMQ3FYOUxzN3BfaE9PeDVXQw?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T12:38:59+00:00", "published_display": "10 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Argent, Peregrine, Newpeak Metals & Caspin", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The West Australian", "published_at": "2026-07-10T05:29:00+00:00", "published_display": "10 Jul 2026 05:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT) Jumps 13%: Is the Biotech Finding a Spark After a Difficult Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQYTBpY2RoYlNoTmJIUUFoanJyZVg1S2RkUVhGemdBNVNzTUk2X2F4Z1czaWZmZWRFbVR6NGJUV3Q5VTJYclhHa1dSVk5TMWJOa3Q3UWp2ZnRXMk1uY2ZzaDBOa05hOUJxUkY0WC1pcXJ2S2NLeVB4bVBsbW1xZjkzNHF0bDRQYXZhNHBETmxOX0c4T2tnTmhEemcwTno0T0szOXVfd24xSnNReWhfS3BOUEhHUkFPd3M2dXRwTHdVVXVHVWhJ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T04:25:00+00:00", "published_display": "09 Jul 2026 04:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX-listed Argent BioPharma signs US$5.5M licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQM1NlcnR2b0VFaTNjVDdNdXI1bUNGUU1KR083a3A2V2hzWll0N2VfYm13Wk9VMERlVndxWDE1NW5aZXdzVndHUnBWUUlkbmo2eUxIcVRDVVFZRk5zVGNTdi1QNUp6N1EwNWpGRDNrMzFJWC1sOXZCbnphQ0dyMUE0VGRiODFRc1Qy?oc=5", "source_name": "grafa.com", "published_at": "2026-07-07T04:46:55+00:00", "published_display": "07 Jul 2026 04:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma (ASX:RGT): Is CannEpil Global Licence Transformative Deal Worth Understanding?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNb3lIQmxKeW40RTBjT1RSenM5RjJWM2pNdlROaF8yeHdTZUZLT2R6SVFRN3kzOFVpZXpzV3pTcW1BMGFMcGtLWUJWbjdDdGdtZ3lSRjktblcxY2tJbFA2RmpXVVJNN2sxdTB3a09iZktNWW0zbzhqMEdIYkVZS0QyTUhON1dPREVKSnlwdkRrd1dFZzRPNHUyRGhzTHgtTHJiQTM0V1lvRHVRQTh3YXBiU2FyZUdOMVN4SW1RX0tVVFFQaXlJTDFnUg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T01:55:00+00:00", "published_display": "07 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma (ASX:RGT) swaps CannEpil rights for US$5.5m in Mercer debt forgiveness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMk91VXRPTHNCQ09kSmV0MUk4UEZaMy1uenQwbTFBLUVScU1ObnBKSWIyOW9LbXZORVBPWXhUbllkbWh1X2NVclJOeE9GV2tCZDhLd0pJb01VejNNVzQ5VWRxY1M0aXBVOEFpaTg2a0Z1MnBPeEtCV0xCendiQTROTmRR?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-07T00:54:52+00:00", "published_display": "07 Jul 2026 00:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX:RGT): Could This Biotech Stock Become a Speculative Healthcare Play?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOZ2VPLVJiM2E4dnV3YVpkTEZ1R1RxdjBKZW92QVptT29haUpRTVJqXy1LZ3dFVzdNVEpqSXJwMDJWb0FCRF9odk15Nkp6b3dHZzVibkExS2FEdjM0NVZWRkxLbVZPZllpMGYyX2dNTkNCXzdGWWs2Zzg4QVNEQWw1cXNCYk04YjI4ZXhuVnRzLXVrc3FpMmRjV1lzbGJsYWt4eFl0YVdKRzR2UXh0Smp5V19CRXMwRUZiNWFKZ3NLQ3ZmQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT): Could This Biopharma Stock Become a High-Risk Watchlist Name?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbUc3VC1ISm5YbktwRlIwekRmbUFFdTdmS0lyYmFqTEJ2bFlJT3RIVWF3RU5xNTB0QnVVeWZCUTEyaHM5WjBkbGp2eVJVQk5KakptTWNMcVdSY1RSWGtWVTNhejIwbVZTQk9qcl9lZGExZUpPaFN6WmFfdzJqNElfUWdJZlBnN0pqZjlVR2hKRGowZVhlejhMVXFFcUNLMmVleVUyamVPUWRJend4MndDekxnYVN1VVJfWE9Ob3B1QzFYZw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma advances epilepsy strategy with CannPal acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPa0ZTWlFLQy1vLUhLSWdGNlhMck4zbjNHb0ZTYjRKM0pnci1TX0RSekdSSHAzZmpHRklrUGhWdDdYTjAzVFBUc2VvQkYxdXZhN1FVWUM5S0hLV3o3MWNtR0ZjNjdIRG53b3pMUEpQckhfQnJySUJaMUVXMS1qMldMU1RaOGNpNzl1SFo5bEZ3NzZYWU80MGQ0UjNBbFZkVXd5eWpkSGNfSQ?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent secures CannPal stake", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma secures significant financing facility to support strategic expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNU0k2MGJCV0RzWUsyOVl2V3d5bEtPVjJhVVplbTU5NzF5N1BtVnZ0MDRyU3NNcVJSTDlvdWh6akhfN0lXRERldVE5SXk4R3ZWbDFJb1dwdzVQb2ktMFdHczlsV3RYckV4OV85SXhqenl3RmJxSExvaE9mdFM3b0xHQTdSNy1FODl1UTFGREdpd3BaLV9Obzdqa1NPdHA4N3RKaDBBd0t4RlVHVnFzeFNQRzRNUGJCM3ZqUzRQTlFrNA?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma secures A$11m facility to complete AusCann acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTmM2cHpUc1JwSzl5cUxLRGRZRWZoVDNkMDJNVlVhVWctTm1zeHJuTThYUjI3Z1Y0dm5reG5ZZENsaDBrQ2djRXZESFEzUkhCenRxZVpGYlBkZkJxckZaQUptajdDUFNoVkM2dGlFdlVMLThXTFAteDlBeUJTbC1wRW94OF9rWk1hdHpmQlozWk1oVVRNOS1zZHU5Sko5WGM?oc=5", "source_name": "Cannabis News Australia", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transformative journey driving Argent BioPharma\u2019s growth and US listing plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPNHpmcGd3TVd6MVhUUnVTVmFMZWZ6VjRjZExLdDFFbWpTNHJ1YzdEMmpwYldaRDl1WDdfdjh4RkxjT2QxVGd6ZEZCTVY2d0V0YjlpZU9xT2dYSXh3a2xqNS12Rnl3WlJ2dE9USXZSVTF6YU83bEozTWY1Nkt1UGpBLWxpR3NndGNpamZBVFJ4OEF1VXZudEZDaE16UC1iRFlyMzl4UDI3ZHN2Y0xYR3c?oc=5", "source_name": "Stockhead", "published_at": "2025-09-03T07:00:00+00:00", "published_display": "03 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Runners of the Week: Kaili, Magnetite Mines, Argent Biopharma, Octava", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQODRtRHJxWlQwQXNfVmM1aFZibThNWUlmNDFFczJnMThXb1NyZnRrTmhKZ3ZGMXlpVmw2a25BU1FRc0lua0VyeHFSRUhVUzQ1bDMwSnkzZ0RSOVhZRUlvTUVtTHlic3dCYnUtWjdNR0JsT3dhZXBOMGRFa281NDRwQXlyeTk5YnktTF93OFJrZmZkTXBCYUJZN2R0LVJCdmR0aXFST29yVGE4MWpKMjQ5cjN1YmZ2aWtzbXNkcHdyZkp4RGZYV0pn?oc=5", "source_name": "SMH.com.au", "published_at": "2025-08-22T07:00:00+00:00", "published_display": "22 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma Jumps 86% After Bold AusCann Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBleUNMV0g3eTc3NllWM3RBMmdZeE05N1ZFWkRQeUoteUo2N1hXeWxncy10NnZRQTFCcXBpbV9XTGp3b1ZVdnYtekVvUnRqSHY0cDRqNUFjUndHQlpXaDV6OVp6VmRia2x2TVltcUpMeEhseW9KN3R0SHhQSQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent acquires key AusCann assets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma becomes latest tech firm to ditch the London Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQQTgwTkpLSGxBQlBYbmhDRUJZVHdkaTdibGlWYVFJaWQwMmhOTUZ1MnY0dTJHbmlaYkVxM2NHWkkyZWwyWFBDQ282TmNJQVNkX0NtaEIwT2E2THE5R2JKeXlzOHR1Sy1EV0hnRWpSLV9Ya1I2OUlsOHhZNHpicHdhNHpxYVFGejZWZjlIaWVPX2M4dzNmaUQ5RlFJVkg4UHg5dk1NUFV3cDQyaHh4anE3Z3piY3JnOUlKTTNId3U3d01vSk1UN2JkSmJB?oc=5", "source_name": "UKTN", "published_at": "2024-11-29T08:00:00+00:00", "published_display": "29 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RGT Stock Price and Chart \u2014 ASX:RGT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBIV0l4bHpPeTJ5UU1rd2VMOUl2VVZFOXc1XzhFVWlPck5lQWoxVGVsTzhOM0tUSF9TQmQ0dWFtRXQ4SC1uZnhSRXFrN292QzFWYU9vN0R3QQ?oc=5", "source_name": "TradingView", "published_at": "2024-04-03T02:52:36+00:00", "published_display": "03 Apr 2024 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma Limited (ASX:RGT) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNVGJjOE10NzFQSGthM1JpRkRXbjg0TU9zdHViY0dKUm5ET3ZZYlU2MV9sU3AycnNacDZXOV9ncGwyVE1jOHlFWEJSSjFCRGVlTFY0UTJoTkVPX09pTDRCdXhDS2pGUUpSYmRrNXdnNmpRSUhhY0pKMzlJdDJjMUpHMWtKNXI?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2024-04-02T18:19:31+00:00", "published_display": "02 Apr 2024 18:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Argent Biopharma Taps ASX for A$262,000 via Convertible Notes and 5.1 Million Unlisted Options", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE15QUg0cWVJWlVUbkFHREUwM0ppcmtQWmtaeVhmejBFbnFXU1lkWGcwX29FV0k1bjZwd0xhM0lzeEhQc2NpOUdVZUJERGhwVlVQbFd3VEt0TDFUZEp3SWdPQ0dnM245WTVJV3JLdm51aEdxODlYWHc?oc=5", "source_name": "finance.biggo.com", "published_at": "2026-07-14T06:31:54+00:00", "published_display": "14 Jul 2026 06:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT) Falls 15% and Is Down Nearly a Quarter Over the Year: Is the Micro-Cap Biotech Facing a Difficult Path?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNcGptZ2NKMkZTWUlYLXBxRkJ2MkM2Sk4zU01vbXVUc2ltSXREd0VrSndxT2dOSzRVU2VObWdJNHFINS1XREZoQWJUQ1BHendWVXdGb2ZsV3VlR1k0STI2NVk4NnVycHppTktvU093dl81RmNSS3ktSkl3X0s3TC1pN2ZnTVp6bUQwQ0g3c2t3YkowaUlvVnQ2dHYxOWlaSkg0MWZQYXY4VnJocVNWNmlQbG0tZnZnNWE5TThzMWk3akJVYjU0by0wellhb0sxbWZZZFNoQnBGckRTeFZINzViZTRkT2FSSi03NWk3OFJMQXhpdEh5UTBv?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T13:48:00+00:00", "published_display": "13 Jul 2026 13:48", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Argent Biopharma Ltd \u2013 ASX:RGT", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNbDE5SzNianlndnZPQkctVEpEOFdmRjBCRG45b1VFVFQ5a2hmZndqZk1IYUVCYndCVUdXWGJLdkVWNHRQRnlEcjZVWU9uQm50QkhjbHpXbE1FMDBkdkxxZnNtU1hhbm9WT3JqMWtGUDN5Uk5GRlhvZ2V5ZGgwN0dqcXpVYUgyLVNMQ3FYOUxzN3BfaE9PeDVXQw?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T12:38:59+00:00", "published_display": "10 Jul 2026 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Argent, Peregrine, Newpeak Metals & Caspin", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The West Australian", "published_at": "2026-07-10T05:29:00+00:00", "published_display": "10 Jul 2026 05:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT) Jumps 13%: Is the Biotech Finding a Spark After a Difficult Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQYTBpY2RoYlNoTmJIUUFoanJyZVg1S2RkUVhGemdBNVNzTUk2X2F4Z1czaWZmZWRFbVR6NGJUV3Q5VTJYclhHa1dSVk5TMWJOa3Q3UWp2ZnRXMk1uY2ZzaDBOa05hOUJxUkY0WC1pcXJ2S2NLeVB4bVBsbW1xZjkzNHF0bDRQYXZhNHBETmxOX0c4T2tnTmhEemcwTno0T0szOXVfd24xSnNReWhfS3BOUEhHUkFPd3M2dXRwTHdVVXVHVWhJ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T04:25:00+00:00", "published_display": "09 Jul 2026 04:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX-listed Argent BioPharma signs US$5.5M licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQM1NlcnR2b0VFaTNjVDdNdXI1bUNGUU1KR083a3A2V2hzWll0N2VfYm13Wk9VMERlVndxWDE1NW5aZXdzVndHUnBWUUlkbmo2eUxIcVRDVVFZRk5zVGNTdi1QNUp6N1EwNWpGRDNrMzFJWC1sOXZCbnphQ0dyMUE0VGRiODFRc1Qy?oc=5", "source_name": "grafa.com", "published_at": "2026-07-07T04:46:55+00:00", "published_display": "07 Jul 2026 04:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma (ASX:RGT): Is CannEpil Global Licence Transformative Deal Worth Understanding?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNb3lIQmxKeW40RTBjT1RSenM5RjJWM2pNdlROaF8yeHdTZUZLT2R6SVFRN3kzOFVpZXpzV3pTcW1BMGFMcGtLWUJWbjdDdGdtZ3lSRjktblcxY2tJbFA2RmpXVVJNN2sxdTB3a09iZktNWW0zbzhqMEdIYkVZS0QyTUhON1dPREVKSnlwdkRrd1dFZzRPNHUyRGhzTHgtTHJiQTM0V1lvRHVRQTh3YXBiU2FyZUdOMVN4SW1RX0tVVFFQaXlJTDFnUg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-07T01:55:00+00:00", "published_display": "07 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma (ASX:RGT) swaps CannEpil rights for US$5.5m in Mercer debt forgiveness", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMk91VXRPTHNCQ09kSmV0MUk4UEZaMy1uenQwbTFBLUVScU1ObnBKSWIyOW9LbXZORVBPWXhUbllkbWh1X2NVclJOeE9GV2tCZDhLd0pJb01VejNNVzQ5VWRxY1M0aXBVOEFpaTg2a0Z1MnBPeEtCV0xCendiQTROTmRR?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-07T00:54:52+00:00", "published_display": "07 Jul 2026 00:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX:RGT): Could This Biotech Stock Become a Speculative Healthcare Play?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOZ2VPLVJiM2E4dnV3YVpkTEZ1R1RxdjBKZW92QVptT29haUpRTVJqXy1LZ3dFVzdNVEpqSXJwMDJWb0FCRF9odk15Nkp6b3dHZzVibkExS2FEdjM0NVZWRkxLbVZPZllpMGYyX2dNTkNCXzdGWWs2Zzg4QVNEQWw1cXNCYk04YjI4ZXhuVnRzLXVrc3FpMmRjV1lzbGJsYWt4eFl0YVdKRzR2UXh0Smp5V19CRXMwRUZiNWFKZ3NLQ3ZmQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma (ASX: RGT): Could This Biopharma Stock Become a High-Risk Watchlist Name?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbUc3VC1ISm5YbktwRlIwekRmbUFFdTdmS0lyYmFqTEJ2bFlJT3RIVWF3RU5xNTB0QnVVeWZCUTEyaHM5WjBkbGp2eVJVQk5KakptTWNMcVdSY1RSWGtWVTNhejIwbVZTQk9qcl9lZGExZUpPaFN6WmFfdzJqNElfUWdJZlBnN0pqZjlVR2hKRGowZVhlejhMVXFFcUNLMmVleVUyamVPUWRJend4MndDekxnYVN1VVJfWE9Ob3B1QzFYZw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma advances epilepsy strategy with CannPal acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPa0ZTWlFLQy1vLUhLSWdGNlhMck4zbjNHb0ZTYjRKM0pnci1TX0RSekdSSHAzZmpHRklrUGhWdDdYTjAzVFBUc2VvQkYxdXZhN1FVWUM5S0hLV3o3MWNtR0ZjNjdIRG53b3pMUEpQckhfQnJySUJaMUVXMS1qMldMU1RaOGNpNzl1SFo5bEZ3NzZYWU80MGQ0UjNBbFZkVXd5eWpkSGNfSQ?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent secures CannPal stake", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma secures significant financing facility to support strategic expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNU0k2MGJCV0RzWUsyOVl2V3d5bEtPVjJhVVplbTU5NzF5N1BtVnZ0MDRyU3NNcVJSTDlvdWh6akhfN0lXRERldVE5SXk4R3ZWbDFJb1dwdzVQb2ktMFdHczlsV3RYckV4OV85SXhqenl3RmJxSExvaE9mdFM3b0xHQTdSNy1FODl1UTFGREdpd3BaLV9Obzdqa1NPdHA4N3RKaDBBd0t4RlVHVnFzeFNQRzRNUGJCM3ZqUzRQTlFrNA?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma secures A$11m facility to complete AusCann acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNTmM2cHpUc1JwSzl5cUxLRGRZRWZoVDNkMDJNVlVhVWctTm1zeHJuTThYUjI3Z1Y0dm5reG5ZZENsaDBrQ2djRXZESFEzUkhCenRxZVpGYlBkZkJxckZaQUptajdDUFNoVkM2dGlFdlVMLThXTFAteDlBeUJTbC1wRW94OF9rWk1hdHpmQlozWk1oVVRNOS1zZHU5Sko5WGM?oc=5", "source_name": "Cannabis News Australia", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transformative journey driving Argent BioPharma\u2019s growth and US listing plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPNHpmcGd3TVd6MVhUUnVTVmFMZWZ6VjRjZExLdDFFbWpTNHJ1YzdEMmpwYldaRDl1WDdfdjh4RkxjT2QxVGd6ZEZCTVY2d0V0YjlpZU9xT2dYSXh3a2xqNS12Rnl3WlJ2dE9USXZSVTF6YU83bEozTWY1Nkt1UGpBLWxpR3NndGNpamZBVFJ4OEF1VXZudEZDaE16UC1iRFlyMzl4UDI3ZHN2Y0xYR3c?oc=5", "source_name": "Stockhead", "published_at": "2025-09-03T07:00:00+00:00", "published_display": "03 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Runners of the Week: Kaili, Magnetite Mines, Argent Biopharma, Octava", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQODRtRHJxWlQwQXNfVmM1aFZibThNWUlmNDFFczJnMThXb1NyZnRrTmhKZ3ZGMXlpVmw2a25BU1FRc0lua0VyeHFSRUhVUzQ1bDMwSnkzZ0RSOVhZRUlvTUVtTHlic3dCYnUtWjdNR0JsT3dhZXBOMGRFa281NDRwQXlyeTk5YnktTF93OFJrZmZkTXBCYUJZN2R0LVJCdmR0aXFST29yVGE4MWpKMjQ5cjN1YmZ2aWtzbXNkcHdyZkp4RGZYV0pn?oc=5", "source_name": "SMH.com.au", "published_at": "2025-08-22T07:00:00+00:00", "published_display": "22 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma Jumps 86% After Bold AusCann Acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTFBleUNMV0g3eTc3NllWM3RBMmdZeE05N1ZFWkRQeUoteUo2N1hXeWxncy10NnZRQTFCcXBpbV9XTGp3b1ZVdnYtekVvUnRqSHY0cDRqNUFjUndHQlpXaDV6OVp6VmRia2x2TVltcUpMeEhseW9KN3R0SHhQSQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent acquires key AusCann assets", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2025-08-19T07:00:00+00:00", "published_display": "19 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent BioPharma becomes latest tech firm to ditch the London Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQQTgwTkpLSGxBQlBYbmhDRUJZVHdkaTdibGlWYVFJaWQwMmhOTUZ1MnY0dTJHbmlaYkVxM2NHWkkyZWwyWFBDQ282TmNJQVNkX0NtaEIwT2E2THE5R2JKeXlzOHR1Sy1EV0hnRWpSLV9Ya1I2OUlsOHhZNHpicHdhNHpxYVFGejZWZjlIaWVPX2M4dzNmaUQ5RlFJVkg4UHg5dk1NUFV3cDQyaHh4anE3Z3piY3JnOUlKTTNId3U3d01vSk1UN2JkSmJB?oc=5", "source_name": "UKTN", "published_at": "2024-11-29T08:00:00+00:00", "published_display": "29 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RGT Stock Price and Chart \u2014 ASX:RGT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTFBIV0l4bHpPeTJ5UU1rd2VMOUl2VVZFOXc1XzhFVWlPck5lQWoxVGVsTzhOM0tUSF9TQmQ0dWFtRXQ4SC1uZnhSRXFrN292QzFWYU9vN0R3QQ?oc=5", "source_name": "TradingView", "published_at": "2024-04-03T02:52:36+00:00", "published_display": "03 Apr 2024 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Argent Biopharma Limited (ASX:RGT) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNVGJjOE10NzFQSGthM1JpRkRXbjg0TU9zdHViY0dKUm5ET3ZZYlU2MV9sU3AycnNacDZXOV9ncGwyVE1jOHlFWEJSSjFCRGVlTFY0UTJoTkVPX09pTDRCdXhDS2pGUUpSYmRrNXdnNmpRSUhhY0pKMzlJdDJjMUpHMWtKNXI?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2024-04-02T18:19:31+00:00", "published_display": "02 Apr 2024 18:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 21, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 18, "score": 50, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "deals", "label": "Deals and strategy", "weight": 3.3, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.07, "latest_week": "2026-07-10", "one_week_move": 100.0, "four_week_move": 94.6, "twelve_week_move": 100.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.114474, "market_dynamics_buy_signal": false, "relative_strength": 10.438436, "fair_value_gap": -82.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 27.7244, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+100.0% over one week, +94.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 5}, {"label": "TradingView", "count": 2}, {"label": "Stocks Down Under", "count": 2}, {"label": "BiotechDispatch", "count": 2}, {"label": "The Australian", "count": 2}, {"label": "finance.biggo.com", "count": 1}, {"label": "The West Australian", "count": 1}, {"label": "grafa.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Deals and strategy", "count": 6}, {"label": "Earnings", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+100.0% over one week, +94.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Argent Biopharma Taps ASX for A$262,000 via Convertible Notes and 5.1 Million Unlisted Options"}], "updated_at": "2026-07-17T05:31:10.638781+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}